glp 1 drugs risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Agonists Weight Loss Drugs

This framing supports the case for continued access to GLP-1 medications even after patients achieve their target weight, which relates to concerns about semaglutide withdrawal symptoms and weight regain after stopping treatment

Those shortages are reportedly easing, with the FDA removing GLP-1 ingredient tirzepatide from its shortage list earlier this month, but many pharmacies are still dealing with empty shelves

[DOI] [PubMed] [Google Scholar] 23.McIntyre N., Holdsworth C.D., Turner D.S

The Nutri-Score is a logo on the overall nutritional quality of products

A.CaoX.SeeleyR

And we expect that number to rise now that one of these drugs, Wegovy, has become available in pill form, increasing its accessibility for many people